Experiencing the Fallout: The Felt Impact of US HIV Funding Reductions Across 13 Sub-Saharan African Countries
This pioneering multi-country qualitative study reveals that 2025 US HIV funding reductions across 13 Sub-Saharan African nations have severely disrupted prevention and treatment services, forced rationing, and caused patient dropouts, prompting stakeholders to adopt adaptive strategies while emphasizing the urgent need for sustainable domestic financing.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For decades, the fight against HIV in sub-Saharan Africa has relied on a massive, coordinated effort to keep people alive and stop the virus from spreading. This effort has depended heavily on money and support from the United States government, which has funded testing, treatment, and prevention programs across the continent. A key part of this strategy involved taking services out of crowded hospitals and bringing them directly to communities. Instead of forcing people to travel long distances to a clinic, health workers would meet them in their neighborhoods, offering medicine, counseling, and prevention tools like condoms or pre-exposure prophylaxis, a daily pill that stops infection before it happens. This approach was designed to reach the most vulnerable people, including young women, sex workers, and men who have sex with men, who often face stigma or barriers when trying to access traditional medical facilities. The system worked because it was flexible, trusting, and built on relationships between health workers and the people they served.
In early 2025, the United States government froze its foreign aid, including the funds that kept these HIV programs running. This sudden stop created a wave of uncertainty across thirteen countries in sub-Saharan Africa, from South Africa to Rwanda. Researchers wanted to know what this actually felt like on the ground. They did not just look at spreadsheets or model future deaths; they wanted to hear the stories of the people managing these programs. To find out, a team of scientists from Germany and various African nations interviewed twenty-six key stakeholders. These were the people running the clinics, advising the governments, and organizing the community networks. They spoke with officials from ministries of health, leaders of non-governmental organizations, and representatives of people living with HIV. The goal was to understand how the sudden loss of funding changed the daily reality of HIV care and what the people in charge were doing to keep the system from collapsing.
What the researchers found was a system in the middle of a painful and rapid transformation. The most immediate change was a shift back to the old way of doing things: centralized care. The community-based models that had brought medicine to doorsteps and set up drop-in centers in neighborhoods were largely dismantled. Mobile clinics stopped running, and the health workers who had built trust with specific groups of people were laid off. Suddenly, people who had been receiving care in familiar, low-stress community settings had to walk or travel long distances to crowded hospitals to get their medication. This shift placed a heavy burden on patients, many of whom could not afford the transport costs. For those who did make the trip, the experience was often more difficult. The specialized, welcoming spaces for young women or key populations were gone, replaced by general hospital wards where patients reported feeling stigmatized and ignored. One health worker in Uganda recounted staff telling patients that if they did not get time to be seen, they might as well die, highlighting a harsh reality where the human connection that kept people in care had been severed.
The disruption went deeper than just where people went for care; it broke the flow of information and supplies. In many places, the machinery of the health system began to stall. While medicines sat in central warehouses, they were not reaching the people who needed them because the transport networks and the staff to manage them had been cut. In Kenya, for instance, the suspension of courier riders and a shortage of blood collection tubes meant that about seventy percent of patients who needed viral load testing could not get their blood drawn or their results returned. Without these results, doctors could not tell if the treatment was working. In Tanzania, machines were present but the service was effectively dead. The loss of staff also meant that critical data was disappearing. Health workers could no longer track who was taking their medicine or who had dropped out of the program, leaving officials guessing about the true state of the epidemic. This invisibility was particularly dangerous for vulnerable groups. Because new rules prevented reporting on specific populations like men who have sex with men or sex workers, these groups effectively vanished from the data, making it impossible to know if they were still accessing care or if they were being left behind entirely.
Despite these severe disruptions, the core treatment for people already living with HIV remained largely intact, but only just. The researchers noted that the Global Fund, another major international donor, stepped in to help fill the gaps, ensuring that most people could still get their antiretroviral drugs. However, the way these drugs were delivered changed drastically. In many countries, the generous practice of giving patients three to six months of medication at once was replaced with one-month or even two-week supplies. This forced patients to visit clinics far more often, increasing their travel costs and the risk that they would simply stop coming. In some places, the uncertainty was so great that providers stopped offering prevention tools like pre-exposure prophylaxis to anyone except pregnant women, even though the drugs were available, because they were confused about which rules applied. The result was a system that was surviving but shrinking, prioritizing the treatment of those already infected while cutting back on the prevention services that stop new infections from happening.
As the dust settled, the people managing these programs were forced to rethink how to keep their systems alive without the steady stream of American money. They began to look inward, exploring ways to fund these services through their own governments, perhaps through taxes or health insurance schemes. Some countries started to integrate HIV services into their general health systems, hoping to make them more efficient and less dependent on outside aid. However, the researchers observed that this transition was uneven and often reactive. In some wealthier nations, there was a sense of confidence that they could manage on their own, while in poorer nations, the reality was a struggle to keep the lights on. Many officials were criticized for being out of touch with the severity of the situation, believing they could simply switch to new donors or find quick fixes. The consensus among the interviewees was that while the immediate crisis of running out of medicine had been averted, the long-term future was precarious. The system was no longer the flexible, community-centered network it once was; it had become a more rigid, facility-based structure that was struggling to reach the most vulnerable people. The study concludes that while the fight against HIV is not over, the path forward requires a fundamental shift toward self-reliance, but one that must be carefully planned to ensure that the gains made over the last two decades are not lost.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.